Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
Sponsor: Ipsen
Summary
This study will collect information from patients with ALGS who are using odevixibat in their daily lives. Odevixibat is a medication that helps patients with ALGS, a rare disease that affects the liver and causes itching. The main aim of this study is to observe the long-term, everyday safety of the drug odevixibat in patients with ALGS who are receiving ongoing treatment.
Official title: Prospective Non-Interventional Study Evaluating the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS)
Key Details
Gender
All
Age Range
6 Months - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2026-07-10
Completion Date
2031-09-30
Last Updated
2026-08-03
Healthy Volunteers
No
Conditions
Locations (14)
Hospices Civils de Lyon - Hopital Femme Mere Enfant
Bron, France
CHU Dijon Bourgogne
Dijon, France
APHP - Hopital Bicetre - Paris Sud
Le Kremlin-Bicêtre, France
APHM - CHU Timone
Marseille, France
CHU de Montpellier - Hopital Saint Eloi
Montpellier, France
APHP - Hopital Necker-Enfants Malades
Paris, France
CHU de Toulouse - Hopital Paule de Viguier
Toulouse, France
APHP - Centre Hepato-Biliaire Hospital Paul Brousse
Villejuif, France
Azienda Ospedaliero Universitaria Meyer
Florence, Italy
Azienda Ospedaliera Di Rilievo Nazionale Santobono Pausilipon
Naples, Italy
University Hospital Of Padova
Padova, Italy
IRCCS Ospedale Pediatrico Bambino Gesu
Roma, Italy
A.O.U. Citta della Salute e della Scienza di Torino - Ospedale Infantile Regina Margherita
Torino, Italy
Ospedale Universitario Di Udine
Udine, Italy